Atlas Trials

A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors

Clinical trial NCT03844438 · UNKNOWN

Trial details

NCT number
NCT03844438
Sponsor
Luye Pharma Group Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2018-12-18
Primary completion
2020-10-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.